3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
51
Neoplasm Metastasis
19
Skin Neoplasms
15
Carcinoma, Renal Cell
13
Leukemia, Myeloid, Acute
12
Kidney Neoplasms
11
Leukemia
9
Neoplasms
7
Uterine Cervical Neoplasms
5
Lymphoma
5
Congenital Abnormalities
5
Breast Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Neuroblastoma
4
Myelodysplastic Syndromes
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Carcinoma, Non-Small-Cell Lung
4
Vaginal Neoplasms
2
Penile Neoplasms
2
Papillomavirus Infections
2
Oropharyngeal Neoplasms
2
Melanoma, Experimental
2
Lymphoma, Mantle-Cell
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Erythroblastic, Acute
2
Brain Neoplasms
2
Interventions
Imatinib Mesylate
6
Cytarabine
5
ponatinib
4
nilotinib
4
venetoclax
3
fludarabine phosphate
3
Mycophenolic Acid
3
thymoglobulin
2
fludarabine
2
enasidenib
2
Methotrexate
2
Lenalidomide
2
Cyclosporine
2
Cyclophosphamide
2
Azacitidine
2
Antilymphocyte Serum
2
quizartinib
1
methanesulfonic acid
1
glasdegib
1
etoposide phosphate
1
daratumumab
1
bosutinib
1
asciminib
1
Whole-Body Irradiation
1
Transplantation
1
Temozolomide
1
Tacrolimus
1
Stem Cell Transplantation
1
Standard of Care
1
RFT5-SMPT-dgA immunotoxin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid
×
aldesleukin
×
Clear all
No trials found.